VJHemOnc is committed to improving our service to you

Myeloma 2017 | Exciting new developments in multiple myeloma

VJHemOnc is committed to improving our service to you

Daniel Auclair, Irene Ghobrial, Jonathan Keats, Larry Boise and Nina Shah

This is an incredibly exciting time for multiple myeloma (MM) research. In this video, some of the most interesting topics presented at the Myeloma 2017 meeting in Edinburgh, UK, are discussed by Daniel Auclair, Senior Vice President of Research, MMRF, Irene Ghobrial, MD, from the Dana-Farber Cancer Institute, Boston, MA, Jonathan Keats, PhD, of the Translational Genomics Research Institute, Phoenix, AZ, Nina Shah, MD, of UCSF Medical Center, San Francisco, CA and Larry Boise, PhD, from Emory University School of Medicine, Atlanta, GA. The developing reality of liquid biopsies, emerging novel subtypes of MM, ground-breaking advances in immunotherapies and exciting improvements in the understanding of resistance mechanisms are discussed. The experts interviewed also provide an overview of the techniques that we could soon see transitioned into clinical use.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter